Spain · Medical and donor conditions

Editorial illustration: clinical consent review beside a laboratory microscope.
Editorial illustration: clinical consent review beside a laboratory microscope.

Spain surrogacy: medical and donor requirements

Short answer

In Spain, the first question is not whether a donor or carrier meets a medical checklist. If the arrangement is that a woman carries a pregnancy for intended parent(s) and agrees to relinquish maternity, Spanish Law 14/2006, article 10, makes the surrogacy contract void whether payment is promised or not. Maternity is determined by childbirth. The law preserves a possible paternity claim by the biological father under ordinary rules, but that is not a general recognition route for intended parents. Spanish assisted-reproduction and gamete-donation standards regulate permitted fertility treatment; they do not make a surrogacy arrangement valid. This article separates binding national rules from clinic protocols and identifies what to verify before signing or paying. The guide reflects the official BOE consolidated texts as of 20 October 2026; a Spanish lawyer should confirm the current official text and regional implementation before reliance.

What the law does — and does not — permit

Article 10(1) says any contract by which a woman agrees to gestate, with or without price, and renounces maternal affiliation in favour of the contracting party or a third party is null as a matter of law. Article 10(2) says filiation is determined by childbirth. Article 10(3) leaves open an action to claim paternity of the biological father under general rules. Therefore, a private contract, clinic protocol, genetic test, donor record or payment receipt cannot by itself remove this legal effect. Nor should a reader infer that a programme is allowed because IVF, egg donation or sperm donation is lawful in other contexts. The rule is about the surrogacy contract and parentage at birth; donor-screening rules answer a different question. Parentage registration, foreign judgments and nationality are outside this article's full scope.

Binding law versus clinic policy

Three national instruments matter. Law 14/2006 governs assisted reproduction, donor contracts, recipients, authorised centres and surrogacy. Royal Decree 412/1996 sets donor-study protocols and additional eligibility and exclusion criteria; its consolidated text still displays the original 1996 update, so the age limits and their interaction with later rules should receive a current Spanish legal check. Royal Decree-law 9/2014 applies to reproductive cells except where Law 14/2006 or its implementing rules cover the issue; Annex IV details screening of gamete donors. Binding legislation is not the same as a clinic's additional age threshold, genetic panel, counselling pathway or funded-treatment criterion. A stricter requirement may come from a regional rule, professional protocol, public-funding condition or clinic policy. Ask which source applies, in writing.

Rules for permitted treatment and recipients

Law 14/2006, article 6, allows a woman over 18 with full legal capacity to receive or use assisted-reproduction techniques after free, conscious and express written consent, regardless of marital status or sexual orientation. That is the rule for permitted ART, not a route to act as a surrogate. Article 3 adds a clinical gate: treatment should be used only when there are reasonable prospects of success, it does not pose a serious physical or psychological risk to the woman or possible offspring, and she has been informed about success, risks and conditions. It permits transfer of no more than three pre-embryos in each woman in each IVF cycle. Article 6 does not state one numerical upper age for every recipient; age-related risk, clinical assessment, regional or public-funding rules and clinic criteria may matter. Article 6(3) also contains wording on a husband's consent for a married woman, subject to a documented separation exception; obtain case-specific advice on its application.

Donor eligibility and screening

Under Law 14/2006, article 5, a gamete donor must be over 18, have good psychophysical health and full legal capacity. Donation is formalised in a written contract with an authorised centre after the donor is told its purpose and consequences. Royal Decree 412/1996, article 2, specifies that female gamete donors must not be older than 35 and male gamete donors must not be older than 50. This is wording in national secondary legislation, not merely an advertised clinic preference, but the decree's consolidated record has not been updated since 1996. For publication or an individual case, confirm the continuing application of these thresholds against current official legislation, regional protocols and the clinic's written policy. A clinic may use a stricter threshold; it should identify whether that is policy or another binding rule. For samples sourced across borders, do not assume that a donor's clearance abroad automatically satisfies Spanish requirements. The applicable screening, traceability and import or transfer documentation depends on the source country, sample type and route; ask the receiving centre to identify the governing requirements and provide the relevant records.

Donor suitability is assessed from personal and family medical history, physical or clinical review and laboratory testing; a generic certificate alone does not prove compliance. Royal Decree 412/1996 identifies transmissible genetic, hereditary or congenital diseases and specified family histories of chromosomal, genetic or metabolic malformations as grounds for exclusion. For third-party gamete donations, Annex IV to Royal Decree-law 9/2014 requires negative serological markers for HIV 1/2, hepatitis C, hepatitis B and syphilis; sperm donors must also test negative for chlamydia using a urine sample and PCR. HTLV-I/II tests are required in relevant high-prevalence or exposure circumstances. Additional tests may be indicated by travel, medical history, infection risk or the type of cells. Donor genetic risk must be assessed for autosomal recessive genes in light of scientific knowledge and known prevalence in the donor's ethnic group, and known hereditary disease in the family must be assessed and explained to recipients. Exact panels and timing may depend on the applicable protocol and clinical circumstances.

For donor sperm, the 2014 rules generally require samples to remain in quarantine for at least 180 days and biological tests to be repeated afterwards. The second test may be omitted in stated circumstances, including where the initial testing used nucleic-acid amplification methods or a validated viral-inactivation process is used during later handling. Do not treat this as a universal six-month rule for every gamete: the provision specifically refers to sperm and includes defined exceptions. Ask the clinic which testing pathway it used, the dates, whether a permitted exception applies and how compliance is documented. A brochure saying “screened” is not the same as a record of the required testing and quarantine pathway.

Anonymity, compensation and limits

Under article 5(5) of Law 14/2006, gamete donation is anonymous and the bank and records must protect donor identity. Recipients and people born through treatment may obtain general information about the donor that does not identify them. Identity may be disclosed only exceptionally, where extraordinary circumstances create a certain danger to the child's life or health, or where criminal procedural law requires it; disclosure must be necessary and restricted and does not determine legal parentage. For sperm donation, article 6(4) gives selection to the medical team, not the recipient's personal choice, and requires the team to seek the greatest possible phenotypic and immunological similarity with the recipient. Do not assume that a clinic can promise an identifiable donor, personal selection or an absolute right to identity. Ask what non-identifying donor profile and information it will provide.

Gamete donation must not be lucrative or commercial. Law 14/2006 allows only compensatory payments strictly covering physical inconvenience and travel or lost-work expenses; they must not act as an economic incentive. Donation may be revoked only if the donor needs the donated gametes for their own use and they remain available; the donor must reimburse costs incurred by the receiving centre. Separately, no more than six children born in Spain may be generated with gametes from the same donor. The donor must disclose previous donations, and the centre must check identity and prior births. Royal Decree 412/1996 also states that a person who has already generated six or more descendants by assisted or unassisted reproduction is excluded as a donor. These are different safeguards: one limits offspring born in Spain from donor gametes; the other concerns the donor's own descendants. Neither creates a payment model for surrogacy, whose contract is void regardless of price.

Quick decision matrix

IssueLegal baseline and practical meaning
Surrogacy contractVoid whether paid or unpaid; maternity is determined by childbirth. A medical checklist, donor screening or clinic licence cannot validate the contract.
Recipient of permitted ARTA woman over 18 with full capacity and free, informed written consent may receive permitted treatment. Clinical safety and success criteria apply; regional, funding or clinic age criteria may add requirements.
Gamete donorAge, capacity, health, written contract, genetic and family history, infectious testing and offspring limits apply. Confirm the current application of the age rule and the exact protocol used.
Clinic policyStricter donor-age limits, extra genetic tests or matching procedures may be clinical practice, regional requirements or clinic policy. Ask for the legal or professional source and whether it is binding. Only authorised centres may perform specified techniques.

Checks before signing or paying

  1. Before paying an agency or clinic, ask it to identify the exact legal service offered in Spain. If it involves a woman carrying a pregnancy under an agreement to relinquish maternity, pause; do not treat an assisted-reproduction licence as approval of surrogacy.
  2. Verify the centre's current authorisation with the competent autonomous-community health authority and confirm that it covers the exact technique and any gamete bank involved. Do not rely only on a website, brand name or intermediary.
  3. Request written answers on donor-age criteria and their legal basis, the screening panel and dates, sperm quarantine and retesting or an exception, genetic-risk assessment, anonymity and information provided, the six-child donor limit, consent forms and fees. Separate statutory duties from clinic policy.

If the programme is abroad

If treatment or birth is planned abroad, the destination country's law and the intended parents' home-country rules may govern different stages. This article does not determine the full outcome in any individual case, including who will ultimately be recorded as a parent or what nationality, passport or travel documents the child may obtain. Do not infer recognition from a foreign certificate or genetic link. Since 1 May 2025, an instruction issued by Spain's Directorate-General for Legal Security and Public Faith tells civil and consular registries not to accept a foreign registry certificate, a simple declaration accompanied by a medical birth certificate, or a final foreign court judgment as a sufficient legal basis for registering the birth and parentage of a child born through surrogacy. It directs that filiation be determined through ordinary Spanish routes, which may include biological filiation and, where the requirements are met, later adoption. This is an administrative registration instruction; it does not decide every child's travel documents or individual route to parentage. Before signing abroad, obtain coordinated advice from counsel in the destination country and the country where parentage or return travel must be recognised, and get written advice on consular documents. These questions are separate from whether a Spanish clinic may provide assisted reproduction.

Practical conclusion: Spain's donor and assisted-reproduction rules are detailed, but they do not create a lawful domestic surrogacy route. Use them to audit permitted fertility treatment, not to infer that a surrogacy programme is authorised. For an individual case, check current BOE text, regional rules and the named centre's authorisation with a Spanish reproductive-law specialist before committing money, medication or consent.

Primary legal and administrative sources

  1. Ley 14/2006, de 26 de mayo, sobre técnicas de reproducción humana asistida — Articles 3–6 and 10.
  2. Real Decreto 412/1996, de 1 de marzo, sobre protocolos obligatorios de estudio de donantes y usuarios — Articles 2–7.
  3. Real Decreto-ley 9/2014, de 4 de julio, sobre calidad y seguridad de células y tejidos humanos — Annex IV.
  4. Instrucción de 28 de abril de 2025, de la Dirección General de Seguridad Jurídica y Fe Pública, sobre actualización del régimen registral de la filiación de los nacimientos mediante gestación por sustitución — administrative instruction on civil-registry registration of parentage after surrogacy; effective 1 May 2025.
  5. The consolidated BOE texts are informational, and current regional implementation and clinic-specific rules require human confirmation.

Last updated:

Author: Khachatrian Razmik, LL.M.

International surrogacy and parentage legal services — LEX SURROGACY by Lex Agency · Author profile · Editorial standards